Cempra Pharmaceuticals, Inc.
170 Southport Drive
Suite 500
Morrisville
North Carolina
27560
United States
Tel: 919-467-1716
Website: http://www.cempra.com/
175 articles about Cempra Pharmaceuticals, Inc.
-
Aerie Pharmaceuticals Announces Appointment of Lily Nguyen as Director, Project Management
5/30/2018
Aerie Pharmaceuticals, Inc. today announced the appointment of Lily Nguyen as Director, Project Management, reporting to Kenneth Ruettimann, Ph.D., Aerie’s Vice President of Manufacturing.
-
Melinta Therapeutics Announces Successful Completion of Merger
11/6/2017
Melinta Therapeutics will commence trading on November 6, 2017 on the NASDAQ Global Market under the symbol "MLNT."
-
Melinta and Cempra Announce Accomplished Executive Leadership Team for Combined Organization
11/1/2017
The company will keep the name Melinta Therapeutics upon the closing of the merger.
-
Melinta and Cempra Name Industry Leader Daniel Wechsler as President and Chief Executive Officer of the Combined Company
10/31/2017
Mr. Wechsler is a seasoned pharma executive with more than 25 years of healthcare experience.
-
New antibiotic development seems to go through cycles and many large companies have stayed away from antibiotics or abandoned efforts, despite a growing need for new antibiotics.
-
Cempra And Melinta Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Merger
9/29/2017
-
Cempra Seals Merger Deal With This Antibiotics Biopharmaceutical
8/9/2017
-
Cempra Provides Corporate Update and Reports Second Quarter 2017 Financial Results
8/9/2017
-
Eight Presentations At ASM Microbe Include Late Breaker From Cempra’s Phase III Fusidic Acid Study And Solithromycin Data On Gonorrhea And Otitis Media
6/2/2017
-
Cempra Presents Data On Ophthalmic Solithromycin At ARVO
5/10/2017
-
Cempra Reshuffles The Deck: Could A Comeback Be In The Cards?
5/2/2017
-
Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
4/28/2017
-
Cempra Presents Data At ECCMID Highlighting Need For New CABP Therapies And Activity Of Solithromycin In Key Population Groups
4/21/2017
-
Troubled Cempra Looks for a Lifeline, Hires Morgan Stanley to Review Options
3/13/2017
-
Troubled Cempra Slashes 67% of Workforce
3/1/2017
-
Is This The Turnaround Cempra Has Been Looking For?
2/27/2017
-
Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals
2/24/2017
-
FDA Rejects Cempra's NDAs for Solithromycin, Shares Sink
12/30/2016
-
Cempra Bids Adieu to Co-Founder and Longtime CEO Dr. Prabha Fernandes, Effective Immediately
12/12/2016
-
FDA Panel Barely Gives a Pass to Cempra's Antibiotic Solithromycin
11/7/2016